Business Context and Reporting Period
Company: 180 Life Sciences Corp. (Note: Metadata listed "FORUM MARKETS Inc" is incorrect based on filing content; the registrant is 180 Life Sciences Corp.)
Filing Type: Form 8-K (Current Report)
Date of Report: December 27, 2024
Event: Entry into a Material Definitive Agreement for a registered direct offering and concurrent private placement.
Key Financial Metrics and Transaction Details
- Securities Issued: 1,200,000 shares of Common Stock and warrants to purchase up to 1,200,000 shares of Common Stock.
- Purchase Price: $2.41 per share and warrant combined.
- Warrant Terms: Immediately exercisable; exercise price of $2.28 per share; expiration 5.5 years from the initial exercise date.
- Expected Net Proceeds: Approximately $2.6 million (after deducting fees and expenses).
- Placement Agent Fees: 7.0% of gross proceeds plus up to $50,000 in expense reimbursement.
- Use of Proceeds: Working capital, general corporate purposes, operationalizing a recently acquired Technology Gaming Platform, and capital expenditures.
Material Changes and Unusual Items
This filing represents a material capital raise event rather than a periodic financial performance report. Consequently, there are no revenue, profit, or margin figures provided in this document. The primary material change is the dilution of existing shareholders through the issuance of new shares and warrants, and the agreement to a 30-day lock-up period for officers, directors, and Series B Preferred Stock holders starting December 30, 2024.
Guidance, Outlook, and Risks
- Closing Conditions: The offering is expected to close on or about December 30, 2024, subject to customary closing conditions.
- Registration Obligations: The Company must file a registration statement for the resale of Warrant Shares within 30 days of the agreement and use commercially reasonable efforts to have it declared effective within 91 days of closing.
- Strategic Outlook: Management intends to utilize funds to develop a recently acquired Technology Gaming Platform, indicating a strategic pivot or expansion into gaming technology.
- Risks: The transaction is contingent on the satisfaction of closing conditions and the effectiveness of the registration statement for warrant shares.
Investor Verification Checklist
- Verify the actual closing date of the offering (expected December 30, 2024) and confirm receipt of net proceeds.
- Confirm the effectiveness of the registration statement for the resale of Warrant Shares within the required 91-day window.
- Review the specific terms of the "Technology Gaming Platform" acquisition to assess the viability of the stated use of proceeds.
- Monitor the 30-day lock-up expiration for insiders to gauge potential near-term selling pressure.
- Check subsequent filings for the final calculation of gross proceeds and exact net proceeds received.